QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
Top-Rated StocksTop-Rated

IQVIA (IQV) Stock Forecast & Price Target

$214.31
-1.96 (-0.91%)
(As of 12/5/2023 ET)
Compare
Today's Range
$212.75
▼
$215.40
50-Day Range
$177.16
▼
$216.91
52-Week Range
$167.42
▼
$241.86
Volume
1.44 million shs
Average Volume
1.11 million shs
Market Capitalization
$39.11 billion
P/E Ratio
36.02
Dividend Yield
N/A
Price Target
$236.57
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

IQVIA Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 14 Analyst Ratings

Analysts' Consensus Price Target

$236.57
10.39% Upside
High Forecast$281.00
Average Forecast$236.57
Low Forecast$202.00
TypeCurrent Forecast
12/5/22 to 12/5/23		1 Month Ago
11/5/22 to 11/5/23		3 Months Ago
9/6/22 to 9/6/23		1 Year Ago
12/5/21 to 12/5/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
12 Buy rating(s)
13 Buy rating(s)
9 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$236.57$238.29$252.00$257.57
Predicted Upside10.39% Upside16.95% Upside19.28% Upside20.85% Upside
Get IQVIA Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for IQV and its competitors with MarketBeat's FREE daily newsletter.


IQV Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

IQV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

IQVIA Stock vs. The Competition

TypeIQVIAMedical CompaniesS&P 500
Consensus Rating Score
2.86
2.67
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside10.39% Upside663.07% Upside4,581.61% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/21/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$240.00+15.50%
11/13/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOverweight ➝ Overweight$262.00 ➝ $239.00+23.73%
11/3/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOverweight ➝ Overweight$240.00 ➝ $225.00+18.11%
11/3/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy ➝ Buy$253.00 ➝ $220.00+15.49%
11/2/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOverweight ➝ Overweight$245.00 ➝ $215.00+12.86%
11/2/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOutperform ➝ Neutral$248.00 ➝ $202.00+12.24%
10/11/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$260.00 ➝ $240.00+19.10%
10/10/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy ➝ Buy$250.00 ➝ $229.00+14.76%
9/6/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageBuy$260.00+17.71%
8/2/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetNeutral ➝ Neutral$200.00 ➝ $225.00+2.70%
8/2/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy$255.00 ➝ $281.00+28.44%
5/1/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$235.00 ➝ $220.00+16.88%
2/13/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOutperform$265.00+14.17%
1/27/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating		S. Davis
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOutperform
12/6/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$251.00+18.44%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 05:16 PM ET.












IQV Price Target - Frequently Asked Questions

What is IQVIA's consensus rating and price target?

According to the issued ratings of 14 analysts in the last year, the consensus rating for IQVIA stock is Moderate Buy based on the current 2 hold ratings and 12 buy ratings for IQV. The average twelve-month price prediction for IQVIA is $236.57 with a high price target of $281.00 and a low price target of $202.00. Learn more on IQV's analyst rating history.

Do Wall Street analysts like IQVIA more than its competitors?

Analysts like IQVIA more than other Medical companies. The consensus rating score for IQVIA is 2.86 while the average consensus rating score for medical companies is 2.67. Learn more on how IQV compares to other companies.

Is IQVIA being downgraded by Wall Street analysts?

Over the previous 90 days, IQVIA's stock had 1 downgrade by analysts.

Does IQVIA's stock price have much upside?

According to analysts, IQVIA's stock has a predicted upside of 16.07% based on their 12-month stock forecasts.

What analysts cover IQVIA?

IQVIA has been rated by Barclays, Evercore ISI, Guggenheim, HSBC, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Robert W. Baird, and Truist Financial in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NYSE:IQV) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -